Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › Relapsing MS Therapy, Lemtrada, Carries Rare But Serious Risk of Stroke and Artery Tears, FDA Warns

  • MS Medications

    Relapsing MS Therapy, Lemtrada, Carries Rare But Serious Risk of Stroke and Artery Tears, FDA Warns

    Posted by MS News Today Moderator on December 11, 2018 at 5:53 pm

    The U.S. FDA is warning that use of Lemtrada, a treatment for relapsing MS, is linked to 13 cases worldwide of stroke and artery rupture. Learn more here.

    Were you aware of these risks associated with Lemtrada? Will you talk to your doctor about this?

    replied 5 years, 4 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .